Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
INTERNAL ONLY STANDING ORDER EMERGENCY DEPARTMENTS METOCLOPRAMIDE HYDROCHLORIDE – Administration by Accredited Emergency Nurses for nausea and/or vomiting POLICY STATEMENT This order may only be activated under the specific circumstances set out in the section “Indications” and provided there are no contraindications present. The administering nurse must be accredited to administer the drug and record the administration in ink on the once only section of the medication chart. This order must be checked and signed by a medical officer within 24 hours, and preferably within 4 hours, of activation of the standing order. This standing order is only valid until the date noted by the Drug and Quality Use of Medicines Committee under the heading "Effective To:" at the end of this document. 1. NURSING ACCREDITATION REQUIREMENTS Accredited Registered Nurses employed within SESLHD Emergency Departments (ED) who are working in a extended practice nurse or Advanced Clinical Nurse (ACN) capacity must have at least a minimum of two (2) years emergency / critical care experience and must be able to work at a minimum of resuscitation level or above (i.e. triage / clinical initiatives nurse) and/or as approved by the ED Nurse Manager. 2. INDICATIONS Adult patients (20 years of age and over) who present to SESLHD Emergency Department (ED) to control nausea and/or vomiting. CONTRAINDICATIONS 1 3. Less than 20 years of age Haemodynamically unstable (meets PACE / Between The Flag criteria2) Where gastrointestinal motility might be dangerous, e.g. in the presence of gastrointestinal haemorrhage, mechanical obstruction or perforation. Phaeochromocytoma. Known hypersensitivity or intolerance to the drug. Porphyria. Epilepsy. The patient is receiving other drugs which are likely to cause extrapyramidal reactions. PRECAUTIONS 1 4. REV 1 Dystonic reactions- occur in approximately 1% of patients given metoclopramide. Neuroleptic malignant syndrome- has been reported with metoclopramide. Previously detected breast cancer Monoamine oxidase inhibitor therapy within 14 days October 2014 Page 1 of 4 INTERNAL ONLY STANDING ORDER EMERGENCY DEPARTMENTS METOCLOPRAMIDE HYDROCHLORIDE – Administration by Accredited Emergency Nurses for nausea and/or vomiting 5. Other- Special care should be taken in cases of severe renal insufficiency. Metoclopramide should be used with caution in patients with hypertension as intravenously administered metoclopramide has been shown to release catecholamines. Metoclopramide can exacerbate parkinsonian symptoms, therefore it should be used with caution, if at all, in patients with parkinsonian syndrome. Use in pregnancy- (Category A) Use in lactation- Adequate human data on use during lactation and adequate animal reproduction studies are not available. ACTIONS/MONITORING REQUIRED Pre administration: Assessment of previous medications utilised i.e. over the counter and/or prescription drugs A full set of vitals (heart rate, blood pressure, respiration rate, temperature) must be taken prior to administration of metoclopramide hydrochloride Documentation: Document patient observations on the ED Standard Adult General Observation (SAGO) Chart and/or electronically within Firstnet. The administering nurse must record the administration in ink on the ‘once-only’ section of the National Inpatient Medication Chart (NIMC) as Emergency Department Standing Order (i.e. “ED SO”) plus print and sign their name. The EDSO drug order must be countersigned by the medical officer that subsequently assesses and treats the patient within 4 hours. The signatures of the administering nurse and nurse checking the medication must be clearly documented on the NIMC and includes completing the date, time, drug, dose, route and time of administration sections. The administering nurse must record in the patient’s progress notes the administration and effect of the medication. Drugs must be checked and ordered according to hospital policy and adhering to the Ministry of Health Policy Medication Handling in NSW Public Health Facilities PD2013_043. Post administration: REV 1 Evaluate and document therapeutic response to the antiemetic. Notify a medical officer if patient meets PACE / Between The Flag criteria2 Monitor for side effects and notify a medical officer if they occur Warn patient not to drive or operate machinery (drowsiness and dizziness may occur) October 2014 Page 2 of 4 INTERNAL ONLY STANDING ORDER EMERGENCY DEPARTMENTS METOCLOPRAMIDE HYDROCHLORIDE – Administration by Accredited Emergency Nurses for nausea and/or vomiting 6. PROTOCOL/ADMINISTRATION GUIDELINES: Caution: CHECK for allergies and/or contraindications Drug Dose 10 mg* Metoclopramide hydrochloride In severe renal impairment: 5 mg Route Frequency Oral OR Intramuscular OR Intravenous Once only Give oral tablet if tolerated. Intravenous injection must be given slowly over 1 to 2 minutes *Halve the dose in severe renal impairment (5 mg) 7. POTENTIAL ADVERSE EFFECTS/INTERACTIONS: Most common side effects: Restlessness, drowsiness, fatigue, and lassitude Less frequent side effects: Insomnia, headache, dizziness, nausea, and bowel disturbances Uncommon side effects: Acute depression, anxiety, and agitation. Acute dystonic reactions, neuroleptic malignant syndrome, hypersensitivity reactions, urinary incontinence and frequency. Interactions: Effects of metoclopramide are antagonised by anticholinergics and narcotic analgesics. Metoclopramide may alter absorption of other orally administered medicines. Altered food absorption may impact diabetic control Additive sedative or extrapyramidal effects REV 1 October 2014 Page 3 of 4 INTERNAL ONLY STANDING ORDER EMERGENCY DEPARTMENTS METOCLOPRAMIDE HYDROCHLORIDE – Administration by Accredited Emergency Nurses for nausea and/or vomiting 8. REFERENCES: 1. MIMMS Online. Metoclopramide Hydrochloride. 2014 [cited 12/9/14] Available from: https://www.mimsonline.com.au.acs.hcn.com.au/Search/FullPI.aspx?ModuleName=Produc t%20Info&searchKeyword=maxolon&PreviousPage=~/Search/QuickSearch.aspx&SearchT ype=&ID=5470003_2 2. SESLHD Patient with Acute Condition for Escalation (PACE): Management of the Deteriorating Adult and Maternity Inpatient SESLHD/PR283. http://www.seslhd.health.nsw.gov.au/Policies_Procedures_Guidelines/Clinical/Other/SESL HDPR283-PACE-MgtOfTheDeterioratingAdultMaternityInpatient.pdf 3. Ministry of Health Policy Medication Handling in NSW Public Health Facilities PD2013_043 http://www0.health.nsw.gov.au/policies/pd/2013/pdf/PD2013_043.pdf Authorised by: Name Designation Signature Professor Gordian Fulde Emergency/ Critical Care Stream Director Date Endorsed by: Name Designation Signature Chair, SESLHD D&QUM Committee REV 1 Date Endorsed Effective To: 30 November 2015 October 2014 Page 4 of 4